ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Eduardo Cazap, MD PhD (President SLACOM)

ISSN: 1754-6605

Submit article

770-highlights-from-the-win-2017-symposium-26-27-june-2017-paris-france-expediting-global-innovation-in-precision-cancer-medicine

Conference Report: Highlights from the WIN 2017 Symposium, 26–27 June 2017, Paris, France: ‘Expediting Global Innovation in Precision Cancer Medicine’

Will Davies

27 Sep 2017

https://doi.org/10.3332/ecancer.2017.770

Abstract | Full Article | PDF

761-malignant-extra-adrenal-pelvic-paraganglioma-in-a-paediatric-patient

Case Report: Malignant extra-adrenal pelvic paraganglioma in a paediatric patient

Gabriel Cao, Julian Mendez, Daniel Navacchia

23 Aug 2017

https://doi.org/10.3332/ecancer.2017.761

Abstract | Full Article | PDF | Spanish

723-clinical-response-in-patients-with-ovarian-cancer-treated-with-metronomic-chemotherapy

Short Communication: Clinical response in patients with ovarian cancer treated with metronomic chemotherapy

Herman Andrés Perroud, O Graciela Scharovsky, Viviana Rosa Rozados, Carlos María Alasino

28 Feb 2017

https://doi.org/10.3332/ecancer.2017.723

Abstract | Full Article | PDF

722-perceived-utility-of-an-integrated-psychological-intervention-for-gynaecological-cancer-patients-admitted-for-surgery-preliminary-data

Clinical Study: Perceived utility of an integrated psychological intervention for gynaecological cancer patients admitted for surgery: preliminary data

Paola Arnaboldi, Serena Oliveri, Valeria Vadilonga, Luigi Santoro, Angelo Maggioni, Gabriella Pravettoni

23 Feb 2017

https://doi.org/10.3332/ecancer.2017.722

Abstract | Full Article | PDF

703-biomarkers-come-of-age-pd1-in-the-frontline-and-cell-cycle-therapy-swells-the-ranks-of-personalised-therapy-in-the-european-society-of-medical-oncology-esmo-congress-copenhagen-7-10-october-2016

Conference Report: Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016

Will Davies

16 Dec 2016

https://doi.org/10.3332/ecancer.2016.703

Abstract | Full Article | PDF

691-cancer-immunotherapy-from-the-lab-to-clinical-applications-potential-impact-on-cancer-centres-organisation

Conference Report: Cancer Immunotherapy: from the lab to clinical applications. Potential impact on cancer centres’ organisation

Linda Cairns, Sandrine Aspeslagh, Andrea Anichini, Jon Amund Kyte, Christian Blank, Paolo Ascierto, Nicolle Rekers, Per Thor Straten, Ahmad Awada

9 Nov 2016

https://doi.org/10.3332/ecancer.2016.691

Abstract | Full Article | PDF

677-veror-radiotherapy-for-low-burden-cancer-789-patients-with-957-lesions

Research: VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

R Orecchia, A Surgo, M Muto, A Ferrari, G Piperno, MA Gerardi, S Comi, C Garibaldi, D Ciardo, A Bazani, F Golino, F Pansini, C Fodor, P Romanelli, D Maestri, V Scroffi, S Mazza, BA Jereczek-Fossa

29 Sep 2016

https://doi.org/10.3332/ecancer.2016.677

Abstract | Full Article | PDF